A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies von Bekaii-Saab, Tanios S, Roda, Julie M, Guenterberg, Kristan D, Ramaswamy, Bhuvanaswari, Young, Donn C, Ferketich, Amy K, Lamb, Tammy A, Grever, Michael R, Shapiro, Charles L, Carson, 3rd, William E

Volltext